Evidence map›Paper›PMID 40174658›Full record

ArticleEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2025

Response to the commentary on "are all measures of liver Kp

Leslie Z Benet, Jasleen K Sodhi

Abstract readLetter
In one paragraph

Article in European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leslie Z BenetDepartment of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, UCSF, 513 Parnassus Ave., Room S-822, San Francisco, CA 94143-0912, USA. Electronic address: leslie.benet@ucsf.edu.
Jasleen K SodhiDepartment of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, UCSF, 513 Parnassus Ave., Room S-822, San Francisco, CA 94143-0912, USA.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

Recently, Sugano commented on our above-titled publication stating that he was a reviewer for the paper. In the Acknowledgements, Sugano indicated that we "kindly suggested publishing the reviewer report as an article". What we had actually written was: "prior to accepting the [unidentified] reviewer's approach, however, we believe he/she would have to publish a paper justifying the methodology and proposing how in vivo clinical data could be analyzed with such methodology". We further explained the fallacy of the accepted mechanistic models of hepatic elimination in a subsequent manuscript titled "Pharmacokinetic theory must consider published experimental data", published online a month after the Sugano commentary became available -not in time for the author to review the full explanation before his commentary was published. Our above-titled publication makes no assumptions or discussions regarding how Kp

Indexed as

Hepatobiliary EliminationLiverModels, BiologicalPharmacokineticsAdministration, OralAnimalsHumansMetabolic Clearance RatePharmaceutical PreparationsPharmaceutical PreparationsExtended clearance modelHepatic bioavailabilityHepatic clearanceKp(uu)Liver to blood ratioProtein binding

Identifiers

PMID40174658
PMCPMC13117299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.